NPH Insulin Versus Insulin Glargine Versus NPH Insulin Plus Insulin Glargine for the Treatment of Dexamethasone-Induced Hyperglycemia in Patients With COVID-19: A Retrospective Cohort Study.

Courtney R FornwaldNatalie S TuttleJulie A Murphy

Published in: The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians (2023)

No difference in the mean POC BG level was observed. Dexamethasone-induced hyperglycemia was poorly controlled in patients with T2DM and COVID-19 infection.

Keyphrases

glycemic control
type diabetes
diabetic rats
high glucose
low dose
high dose
drug induced
adipose tissue
insulin resistance
replacement therapy
endothelial cells
combination therapy